Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study

• Autors principals: Nan-Chang Chiu (Autor), Li-Min Huang (Autor), Arnold Willemsen (Autor), Chiranjiwi Bhusal (Autor), Ashwani Kumar Arora (Autor), Zenaida Reynoso Mojares (Autor), Daniela Toneatto (Autor)
• Format: Llibre
• Publicat: Taylor & Francis Group, 2018-05-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Neisseria meningitidis is associated with high mortality and morbidity in infants and children worldwide. This phase 3 study (NCT02173704) evaluated safety and immunogenicity of a 4-component serogroup B recombinant meningococcal vaccine (4CMenB) co-administered with routine vaccines in Taiwanese in...